This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David James Haddon: Innovator in Rheumatology
Introduction
David James Haddon is a notable inventor based in Millbrae, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach has led to the development of a patent that addresses critical health issues.
Latest Patents
Haddon holds a patent for "Methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosus using an inhibitor of Bruton's tyrosine kinase." This patent focuses on the use of fenebrutinib, an inhibitor of Bruton's tyrosine kinase, or a pharmaceutically acceptable salt thereof, to treat these conditions effectively.
Career Highlights
David James Haddon is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative therapies. His work at Genentech has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his coworkers include Alyssa Mariko Morimoto and Tamiko Katsumoto. Their collective expertise contributes to the advancement of research and development in the treatment of autoimmune diseases.
Conclusion
David James Haddon is a pioneering inventor whose work has the potential to improve the lives of many individuals suffering from autoimmune diseases. His contributions to medical science are invaluable and reflect his commitment to innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile